<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Semaglutide Pills Comparison</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            padding: 40px 20px;
            min-height: 100vh;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
            background: white;
            border-radius: 30px;
            overflow: hidden;
            box-shadow: 0 20px 60px rgba(0,0,0,0.3);
        }
        
        .header {
            background: linear-gradient(135deg, #1e3c72 0%, #2a5298 100%);
            color: white;
            padding: 50px 40px;
            text-align: center;
        }
        
        .header h1 {
            font-size: 42px;
            margin-bottom: 15px;
            font-weight: 700;
        }
        
        .header p {
            font-size: 20px;
            opacity: 0.9;
        }
        
        .alert-banner {
            background: #dc2626;
            color: white;
            padding: 30px;
            text-align: center;
            font-size: 18px;
            font-weight: 600;
            border-bottom: 4px solid #991b1b;
        }
        
        .comparison-section {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 0;
        }
        
        .product-card {
            padding: 50px 40px;
            position: relative;
        }
        
        .hims-card {
            background: linear-gradient(to bottom, #fef3c7 0%, #fde68a 100%);
            border-right: 3px solid #d97706;
        }
        
        .wegovy-card {
            background: linear-gradient(to bottom, #dbeafe 0%, #bfdbfe 100%);
        }
        
        .product-header {
            margin-bottom: 35px;
        }
        
        .product-name {
            font-size: 32px;
            font-weight: 700;
            margin-bottom: 10px;
            display: flex;
            align-items: center;
            gap: 15px;
        }
        
        .warning-badge {
            background: #dc2626;
            color: white;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 14px;
            font-weight: 700;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }
        
        .approved-badge {
            background: #059669;
            color: white;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 14px;
            font-weight: 700;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }
        
        .company {
            font-size: 18px;
            color: #6b7280;
            font-weight: 500;
        }
        
        .price-box {
            background: white;
            border-radius: 15px;
            padding: 25px;
            margin-bottom: 30px;
            border-left: 6px solid #2563eb;
            box-shadow: 0 4px 12px rgba(0,0,0,0.1);
        }
        
        .price-label {
            font-size: 14px;
            color: #6b7280;
            margin-bottom: 8px;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 1px;
        }
        
        .price {
            font-size: 48px;
            font-weight: 800;
            color: #1e40af;
            line-height: 1;
        }
        
        .price-details {
            font-size: 15px;
            color: #4b5563;
            margin-top: 10px;
            line-height: 1.6;
        }
        
        .section {
            margin-bottom: 35px;
        }
        
        .section-title {
            font-size: 20px;
            font-weight: 700;
            margin-bottom: 18px;
            color: #1f2937;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .icon {
            width: 28px;
            height: 28px;
        }
        
        .feature-list {
            list-style: none;
        }
        
        .feature-item {
            padding: 15px 0;
            border-bottom: 1px solid rgba(0,0,0,0.1);
            display: flex;
            align-items: flex-start;
            gap: 12px;
            font-size: 15px;
            line-height: 1.6;
        }
        
        .feature-item:last-child {
            border-bottom: none;
        }
        
        .check {
            color: #059669;
            font-weight: bold;
            font-size: 20px;
            flex-shrink: 0;
        }
        
        .x-mark {
            color: #dc2626;
            font-weight: bold;
            font-size: 20px;
            flex-shrink: 0;
        }
        
        .warning-mark {
            color: #d97706;
            font-weight: bold;
            font-size: 20px;
            flex-shrink: 0;
        }
        
        .regulatory-box {
            background: #fee2e2;
            border: 3px solid #dc2626;
            border-radius: 15px;
            padding: 25px;
            margin-bottom: 25px;
        }
        
        .regulatory-title {
            font-size: 18px;
            font-weight: 700;
            color: #991b1b;
            margin-bottom: 15px;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .regulatory-text {
            font-size: 15px;
            line-height: 1.7;
            color: #7f1d1d;
        }
        
        .key-differences {
            background: #f9fafb;
            padding: 50px 40px;
            border-top: 3px solid #e5e7eb;
        }
        
        .key-differences h2 {
            font-size: 32px;
            margin-bottom: 35px;
            text-align: center;
            color: #1f2937;
        }
        
        .difference-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 25px;
        }
        
        .difference-card {
            background: white;
            border-radius: 15px;
            padding: 25px;
            box-shadow: 0 4px 12px rgba(0,0,0,0.08);
            border-left: 5px solid #ef4444;
        }
        
        .difference-card h3 {
            font-size: 18px;
            font-weight: 700;
            margin-bottom: 12px;
            color: #dc2626;
        }
        
        .difference-card p {
            font-size: 15px;
            line-height: 1.7;
            color: #4b5563;
        }
        
        .footer {
            background: #1f2937;
            color: white;
            padding: 30px;
            text-align: center;
            font-size: 13px;
            line-height: 1.8;
        }
        
        .highlight {
            background: #fef08a;
            padding: 2px 6px;
            border-radius: 3px;
            font-weight: 600;
        }
        
        .bold {
            font-weight: 700;
        }
        
        @media (max-width: 968px) {
            .comparison-section {
                grid-template-columns: 1fr;
            }
            
            .hims-card {
                border-right: none;
                border-bottom: 3px solid #d97706;
            }
            
            .header h1 {
                font-size: 32px;
            }
            
            .price {
                font-size: 36px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>üîç Semaglutide Pills Showdown</h1>
            <p>FDA-Approved vs. Compounded: The Regulatory Gap</p>
        </div>
        
        <div class="alert-banner">
            ‚ö†Ô∏è KEY ISSUE: Hims & Hers is using a "personalized dosing" loophole to bypass FDA approval requirements ‚Äî even after the semaglutide shortage officially ended in February 2025
        </div>
        
        <div class="comparison-section">
            <!-- Hims & Hers Card -->
            <div class="product-card hims-card">
                <div class="product-header">
                    <div class="product-name">
                        Hims & Hers Pill
                        <span class="warning-badge">Not FDA Approved</span>
                    </div>
                    <div class="company">Hims & Hers Health, Inc.</div>
                </div>
                
                <div class="price-box">
                    <div class="price-label">Pricing</div>
                    <div class="price">$49</div>
                    <div class="price-details">
                        First month introductory<br>
                        Then $99/month ongoing
                    </div>
                </div>
                
                <div class="regulatory-box">
                    <div class="regulatory-title">
                        ‚ö†Ô∏è Regulatory Status
                    </div>
                    <div class="regulatory-text">
                        <span class="bold">Compounded drug</span> ‚Äî NOT approved by FDA. Uses the "compounding exception" claiming "personalized dosing" to continue sales after shortage ended. Novo Nordisk calling this <span class="highlight">"illegal mass compounding"</span> and threatening legal action.
                    </div>
                </div>
                
                <div class="section">
                    <div class="section-title">
                        <span class="icon">‚öñÔ∏è</span>
                        The Loophole Strategy
                    </div>
                    <ul class="feature-list">
                        <li class="feature-item">
                            <span class="warning-mark">‚ö†Ô∏è</span>
                            <span>Originally sold during FDA shortage (503A/503B compounding exception allowed during shortages)</span>
                        </li>
                        <li class="feature-item">
                            <span class="warning-mark">‚ö†Ô∏è</span>
                            <span>FDA ended semaglutide shortage in <span class="bold">February 2025</span></span>
                        </li>
                        <li class="feature-item">
                            <span class="warning-mark">‚ö†Ô∏è</span>
                            <span>Now claims "personalized dosing" justifies continued compounding ‚Äî critics say minor dose adjustments don't qualify</span>
                        </li>
                        <li class="feature-item">
                            <span class="warning-mark">‚ö†Ô∏è</span>
                            <span>Launched pill version days after Wegovy pill approval to undercut pricing</span>
                        </li>
                    </ul>
                </div>
                
                <div class="section">
                    <div class="section-title">
                        <span class="icon">‚ùå</span>
                        What's Missing
                    </div>
                    <ul class="feature-list">
                        <li class="feature-item">
                            <span class="x-mark">‚úó</span>
                            <span><span class="bold">No FDA approval</span> ‚Äî never went through rigorous clinical trials</span>
                        </li>
                        <li class="feature-item">
                            <span class="x-mark">‚úó</span>
                            <span>Not evaluated for safety, effectiveness, or quality by FDA</span>
                        </li>
                        <li class="feature-item">
                            <span class="x-mark">‚úó</span>
                            <span>Uses different formulation (semaglutide sodium/acetate) than FDA-approved version</span>
                        </li>
                        <li class="feature-item">
                            <span class="x-mark">‚úó</span>
                            <span>No guarantee of consistent dosing or purity</span>
                        </li>
                        <li class="feature-item">
                            <span class="x-mark">‚úó</span>
                            <span>Super Bowl ad didn't list side effects or FDA warnings (violating FDCA)</span>
                        </li>
                    </ul>
                </div>
                
                <div class="section">
                    <div class="section-title">
                        <span class="icon">‚öïÔ∏è</span>
                        Clinical Data
                    </div>
                    <ul class="feature-list">
                        <li class="feature-item">
                            <span class="x-mark">‚úó</span>
                            <span>No published clinical trial data</span>
                        </li>
                        <li class="feature-item">
                            <span class="x-mark">‚úó</span>
                            <span>No FDA review of safety or efficacy</span>
                        </li>
                        <li class="feature-item">
                            <span class="warning-mark">‚ö†Ô∏è</span>
                            <span>Reports of adverse events and inconsistent dosages</span>
                        </li>
                    </ul>
                </div>
            </div>
            
            <!-- Wegovy Card -->
            <div class="product-card wegovy-card">
                <div class="product-header">
                    <div class="product-name">
                        Wegovy Pill
                        <span class="approved-badge">‚úì FDA Approved</span>
                    </div>
                    <div class="company">Novo Nordisk</div>
                </div>
                
                <div class="price-box">
                    <div class="price-label">Pricing</div>
                    <div class="price">$149</div>
                    <div class="price-details">
                        1.5mg & 4mg doses/month<br>
                        $299/month for 9mg & 25mg doses<br>
                        ~$25 or less with insurance
                    </div>
                </div>
                
                <div class="regulatory-box" style="background: #dcfce7; border-color: #059669;">
                    <div class="regulatory-title" style="color: #065f46;">
                        ‚úì Full FDA Approval
                    </div>
                    <div class="regulatory-text" style="color: #064e3b;">
                        <span class="bold">First and only FDA-approved oral GLP-1 for weight loss.</span> Went through complete clinical trial process and rigorous FDA review. Approved December 2025, launched January 2026.
                    </div>
                </div>
                
                <div class="section">
                    <div class="section-title">
                        <span class="icon">‚úÖ</span>
                        FDA Approval Process
                    </div>
                    <ul class="feature-list">
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Completed Phase 3 clinical trials (OASIS 4 program)</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>64-week trial with 307 participants</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Full FDA safety and efficacy review</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Quality standards enforced by FDA</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Manufactured in FDA-registered North Carolina facilities</span>
                        </li>
                    </ul>
                </div>
                
                <div class="section">
                    <div class="section-title">
                        <span class="icon">üìä</span>
                        Proven Results
                    </div>
                    <ul class="feature-list">
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span><span class="bold">16.6% mean weight loss</span> at 64 weeks (vs 2.7% placebo)</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>1 in 3 participants achieved ‚â•20% weight loss</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Similar efficacy to injectable Wegovy 2.4mg</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Published in New England Journal of Medicine</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Also proven to reduce cardiovascular events (SELECT trial)</span>
                        </li>
                    </ul>
                </div>
                
                <div class="section">
                    <div class="section-title">
                        <span class="icon">üõ°Ô∏è</span>
                        Safety & Quality
                    </div>
                    <ul class="feature-list">
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>FDA-reviewed safety profile</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Consistent, reliable dosing</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Quality manufacturing standards</span>
                        </li>
                        <li class="feature-item">
                            <span class="check">‚úì</span>
                            <span>Complete prescribing information available</span>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
        <div class="key-differences">
            <h2>üö® The Critical Regulatory Differences</h2>
            <div class="difference-grid">
                <div class="difference-card">
                    <h3>‚öñÔ∏è Legal Status</h3>
                    <p><strong>Hims & Hers:</strong> Exploiting a compounding loophole meant for genuine personalization needs. Novo Nordisk threatening legal action for "illegal mass compounding." FDA warned about deceptive advertising.</p>
                    <p><strong>Wegovy:</strong> Full FDA approval with legal market authorization.</p>
                </div>
                
                <div class="difference-card">
                    <h3>üî¨ Clinical Evidence</h3>
                    <p><strong>Hims & Hers:</strong> No clinical trials, no peer-reviewed data, no FDA efficacy review.</p>
                    <p><strong>Wegovy:</strong> Rigorous Phase 3 trials, published results, proven 16.6% weight loss.</p>
                </div>
                
                <div class="difference-card">
                    <h3>üíä Active Ingredient</h3>
                    <p><strong>Hims & Hers:</strong> Different salt formulations (semaglutide sodium or acetate) ‚Äî chemically distinct from FDA-approved version.</p>
                    <p><strong>Wegovy:</strong> Exact same semaglutide as FDA-approved injectable.</p>
                </div>
                
                <div class="difference-card">
                    <h3>üè≠ Manufacturing</h3>
                    <p><strong>Hims & Hers:</strong> Compounding facilities ‚Äî less regulatory oversight than FDA-approved manufacturing.</p>
                    <p><strong>Wegovy:</strong> FDA-registered pharmaceutical manufacturing in North Carolina with strict quality controls.</p>
                </div>
                
                <div class="difference-card">
                    <h3>üí∞ The Price Gap</h3>
                    <p><strong>Why the difference?</strong> Hims & Hers avoids the massive R&D, clinical trial, and FDA approval costs (estimated at $1+ billion). They're selling a copycat during what FDA says is no longer a shortage.</p>
                </div>
                
                <div class="difference-card">
                    <h3>‚è±Ô∏è Timeline Controversy</h3>
                    <p><strong>The Problem:</strong> Hims & Hers launched their pill version just DAYS after Wegovy pill approval, clearly attempting to undercut the FDA-approved option on price. FDA ended shortage in Feb 2025, but compounders claiming "personalization" to keep selling.</p>
                </div>
            </div>
        </div>
        
        <div class="footer">
            <strong>Bottom Line:</strong> Hims & Hers is bypassing the rigorous FDA approval process by claiming their mass-produced compounded semaglutide qualifies as "personalized medicine."<br>
            The FDA compounding exception was designed for genuine patient-specific needs (like dye allergies or custom strengths), not as a loophole to avoid clinical trials and sell cheaper copies of patented drugs.<br><br>
            <strong>Source Data:</strong> FDA announcements, Novo Nordisk press releases, clinical trial publications (NEJM), Fierce Healthcare, Pharmaceutical Times (Feb 2026). Created February 2026.
        </div>
    </div>
</body>
</html>
